← Back to all trials
Withdrawn
NCT05224557
Analysis of Cardiac Biomarker Racial Discrepancies
Conditions: Heart Failure
Sex: All
Ages: 18 Years – N/A
Sponsor: Methodist Health System
Location: Methodist Dallas Medical Center Dallas Texas
Summary
The goal is to review cardiac biomarkers present on admission between African American patients with new onset Heart Failure compared to a comparable cohort of Caucasian patients to establish whether there is a clinically significant difference between the two groups regarding cardiac biomarker levels and initial Heart Failure severity.
Hypothesis: Cardiac biomarker levels in African American patients with new onset Heart Failure with Reduced Ejection Fraction will be significantly lower than a Caucasian cohort with new onset Heart Failure with Reduced Ejection Fraction.
Eligibility Criteria
Inclusion Criteria:
* \>18 years
* Self-identified as AA
* Self-identified as Caucasian
* NYHA class II-IV symptoms
* Left ventricle EF \
Source: ClinicalTrials.gov (NCT05224557). StuddyBuddy aggregates publicly available trial information.
